Delivery Order SPE2DB22D3011-SPE2DB24FQ2FZ
Award Date
6/28/24
Potential Completion Date
7/22/24
Potential Value
$4.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $36,068.40, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is a delivery order for the pharmaceutical product GAMUNEX-C, a 10 gram/100 ml vial. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,076.11, is for the delivery of GAMUNEX-C 20 gram/200 mL vials. The contract is a Firm Fixed Price delivery order with a completion date of May 30, 2023. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,462.92 firm fixed-price delivery order is for the supply of GAMUNEX-C 40 GRAM/400 ML VIAL 400 ML medical products. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of GAMUNEX-C 40 gram/400 ml vials. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $29,851.68 and a performance period through January 17, 2025. AmerisourceBergen is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,765 Firm Fixed Price delivery order is for the supply of GAMUNEX-C 20 gram/200 mL vials, with a period of performance through November 25, 2024. The contract does not utilize a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that is a subsidiary of Amerisourcebergen Corporation. The $23,825.00 Delivery Order contract is for the supply of GAMUNEX-C 20 gram/200 ml vials, a prescription immune globulin medication. The contract is not set aside and is a Firm Fixed Price agreement with a completion date of June 13, 2024. Amerisourcebergen holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,034.20 firm fixed-price delivery order (SPE2DB20D3103|SPE2DB25FL4A5) is for the supply of GAMUNEX-C 10 gram/100 ml vials, with a period of performance through November 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $14,295.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML, a pharmaceutical product, with a completion date of July 18, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December...
This is a federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract, valued at $4,809.08, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a Department of Defense (DoD) agency, and has a completion date of July 2, 2024. The contract is a Delivery Order on a Firm Fixed Price basis, with no set-aside designation. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $24,045.40 firm fixed-price delivery order is for the supply of GAMUNEX-C 40 gram/400 ml vials, a specialty pharmaceutical product. The contract does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which...